161 related articles for article (PubMed ID: 10949926)
21. Binding of bovine papillomavirus type 4 E8 to ductin (16K proteolipid), down-regulation of gap junction intercellular communication and full cell transformation are independent events.
Ashrafi GH; Pitts JD; Faccini A; McLean P; O'Brien V; Finbow ME; Campo S
J Gen Virol; 2000 Mar; 81(Pt 3):689-94. PubMed ID: 10675405
[TBL] [Abstract][Full Text] [Related]
22. Mapping of the intermolecular association of human T cell leukaemia/lymphotropic virus type I p12I and the vacuolar H+-ATPase 16 kDa subunit protein.
Koralnik IJ; Mulloy JC; Andresson T; Fullen J; Franchini G
J Gen Virol; 1995 Aug; 76 ( Pt 8)():1909-16. PubMed ID: 7636472
[TBL] [Abstract][Full Text] [Related]
23. Vacuolar H(+)-ATPase mutants transform cells and define a binding site for the papillomavirus E5 oncoprotein.
Andresson T; Sparkowski J; Goldstein DJ; Schlegel R
J Biol Chem; 1995 Mar; 270(12):6830-7. PubMed ID: 7896830
[TBL] [Abstract][Full Text] [Related]
24. The BPV-1 E5 oncoprotein expressed in Schizosaccharomyces pombe exhibits normal biochemical properties and binds to the endogenous 16-kDa component of the vacuolar proton-ATPase.
Goldstein DJ; Toyama R; Dhar R; Schlegel R
Virology; 1992 Oct; 190(2):889-93. PubMed ID: 1387753
[TBL] [Abstract][Full Text] [Related]
25. The E5 protein of the human papillomavirus type 16 modulates composition and dynamics of membrane lipids in keratinocytes.
Bravo IG; Crusius K; Alonso A
Arch Virol; 2005 Feb; 150(2):231-46. PubMed ID: 15503216
[TBL] [Abstract][Full Text] [Related]
26. Human papillomavirus E5 protein induces expression of the EP4 subtype of prostaglandin E2 receptor in cyclic AMP response element-dependent pathways in cervical cancer cells.
Oh JM; Kim SH; Lee YI; Seo M; Kim SY; Song YS; Kim WH; Juhnn YS
Carcinogenesis; 2009 Jan; 30(1):141-9. PubMed ID: 18849297
[TBL] [Abstract][Full Text] [Related]
27. Golgi alkalinization by the papillomavirus E5 oncoprotein.
Schapiro F; Sparkowski J; Adduci A; Suprynowicz F; Schlegel R; Grinstein S
J Cell Biol; 2000 Jan; 148(2):305-15. PubMed ID: 10648563
[TBL] [Abstract][Full Text] [Related]
28. The BPV-1 E5 protein, the 16 kDa membrane pore-forming protein and the PDGF receptor exist in a complex that is dependent on hydrophobic transmembrane interactions.
Goldstein DJ; Andresson T; Sparkowski JJ; Schlegel R
EMBO J; 1992 Dec; 11(13):4851-9. PubMed ID: 1334459
[TBL] [Abstract][Full Text] [Related]
29. Targeted disruption of the epidermal growth factor receptor inhibits development of papillomas and carcinomas from human papillomavirus-immortalized keratinocytes.
Woodworth CD; Gaiotti D; Michael E; Hansen L; Nees M
Cancer Res; 2000 Aug; 60(16):4397-402. PubMed ID: 10969784
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus type 16 E5 protein localizes to the Golgi apparatus but does not grossly affect cellular glycosylation.
Oetke C; Auvinen E; Pawlita M; Alonso A
Arch Virol; 2000; 145(10):2183-91. PubMed ID: 11087100
[TBL] [Abstract][Full Text] [Related]
31. [Prokaryotic expression and identification of human papillomavirus type 16 E5 protein].
Shi QF; Wei XL; Li H; Wang BN; Zhang WD; Jiang ZH; Cao K; Li MY
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):31-5. PubMed ID: 16495171
[TBL] [Abstract][Full Text] [Related]
32. HPV16 E5 protein disrupts the c-Cbl-EGFR interaction and EGFR ubiquitination in human foreskin keratinocytes.
Zhang B; Srirangam A; Potter DA; Roman A
Oncogene; 2005 Apr; 24(15):2585-8. PubMed ID: 15735736
[TBL] [Abstract][Full Text] [Related]
33. The human T-cell leukemia/lymphotropic virus type I p12I protein cooperates with the E5 oncoprotein of bovine papillomavirus in cell transformation and binds the 16-kilodalton subunit of the vacuolar H+ ATPase.
Franchini G; Mulloy JC; Koralnik IJ; Lo Monico A; Sparkowski JJ; Andresson T; Goldstein DJ; Schlegel R
J Virol; 1993 Dec; 67(12):7701-4. PubMed ID: 8230493
[TBL] [Abstract][Full Text] [Related]
34. E5 transforming proteins of papillomaviruses do not disturb the activity of the vacuolar H(+)-ATPase.
Ashby ADM; Meagher L; Campo MS; Finbow ME
J Gen Virol; 2001 Oct; 82(Pt 10):2353-2362. PubMed ID: 11562529
[TBL] [Abstract][Full Text] [Related]
35. Requirement of epidermal growth factor receptor for hyperplasia induced by E5, a high-risk human papillomavirus oncogene.
Genther Williams SM; Disbrow GL; Schlegel R; Lee D; Threadgill DW; Lambert PF
Cancer Res; 2005 Aug; 65(15):6534-42. PubMed ID: 16061632
[TBL] [Abstract][Full Text] [Related]
36. Vascular endothelial growth factor (VEGF) up-regulates epidermal growth factor receptor (EGF-R) in cervical cancer in vitro: this action is mediated through HPV-E6 in HPV-positive cancers.
Mathur RS; Mathur SP
Gynecol Oncol; 2005 Apr; 97(1):206-13. PubMed ID: 15790460
[TBL] [Abstract][Full Text] [Related]
37. Activity of the human papillomavirus E6 PDZ-binding motif correlates with an enhanced morphological transformation of immortalized human keratinocytes.
Watson RA; Thomas M; Banks L; Roberts S
J Cell Sci; 2003 Dec; 116(Pt 24):4925-34. PubMed ID: 14625386
[TBL] [Abstract][Full Text] [Related]
38. Concanamycin and indolyl pentadieneamide inhibitors of the vacuolar H+-ATPase bind with high affinity to the purified proteolipid subunit of the membrane domain.
Whyteside G; Meek PJ; Ball SK; Dixon N; Finbow ME; Kee TP; Findlay JB; Harrison MA
Biochemistry; 2005 Nov; 44(45):15024-31. PubMed ID: 16274249
[TBL] [Abstract][Full Text] [Related]
39. The bovine papillomavirus type 4 E8 protein binds to ductin and causes loss of gap junctional intercellular communication in primary fibroblasts.
Faccini AM; Cairney M; Ashrafi GH; Finbow ME; Campo MS; Pitts JD
J Virol; 1996 Dec; 70(12):9041-5. PubMed ID: 8971040
[TBL] [Abstract][Full Text] [Related]
40. A mutational analysis of the transforming functions of the E8 protein of bovine papillomavirus type 4.
O'Brien V; Ashrafi GH; Grindlay GJ; Anderson R; Campo MS
Virology; 1999 Mar; 255(2):385-94. PubMed ID: 10069964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
